A glutamine-based single α-helix scaffold to target globular proteins
- PMID: 36400768
- PMCID: PMC9674830
- DOI: 10.1038/s41467-022-34793-6
A glutamine-based single α-helix scaffold to target globular proteins
Abstract
The binding of intrinsically disordered proteins to globular ones can require the folding of motifs into α-helices. These interactions offer opportunities for therapeutic intervention but their modulation with small molecules is challenging because they bury large surfaces. Linear peptides that display the residues that are key for binding can be targeted to globular proteins when they form stable helices, which in most cases requires their chemical modification. Here we present rules to design peptides that fold into single α-helices by instead concatenating glutamine side chain to main chain hydrogen bonds recently discovered in polyglutamine helices. The resulting peptides are uncharged, contain only natural amino acids, and their sequences can be optimized to interact with specific targets. Our results provide design rules to obtain single α-helices for a wide range of applications in protein engineering and drug design.
© 2022. The Author(s).
Conflict of interest statement
M.B. and X.S. are founders of Nuage Therapeutics. M.B. is an employee of Nuage Therapeutics. X.S. is a scientific advisor of Nuage Therapeutics. The remaining authors declare no competing interests.
Figures






Similar articles
-
A hydrogen bond surrogate approach for stabilization of short peptide sequences in alpha-helical conformation.Acc Chem Res. 2008 Oct;41(10):1289-300. doi: 10.1021/ar700264k. Epub 2008 Jul 17. Acc Chem Res. 2008. PMID: 18630933 Free PMC article.
-
The occurrence of C--H...O hydrogen bonds in alpha-helices and helix termini in globular proteins.Proteins. 2004 Sep 1;56(4):768-81. doi: 10.1002/prot.20152. Proteins. 2004. PMID: 15281129
-
Alpha helix capping in synthetic model peptides by reciprocal side chain-main chain interactions: evidence for an N terminal "capping box".Proteins. 1994 Jan;18(1):1-7. doi: 10.1002/prot.340180103. Proteins. 1994. PMID: 8146119
-
The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.Chem Biodivers. 2004 Aug;1(8):1111-239. doi: 10.1002/cbdv.200490087. Chem Biodivers. 2004. PMID: 17191902 Review.
-
Peptide design using alpha,beta-dehydro amino acids: from beta-turns to helical hairpins.Biopolymers. 2004;76(2):150-61. doi: 10.1002/bip.10571. Biopolymers. 2004. PMID: 15054895 Review.
Cited by
-
Reviewing the Structure-Function Paradigm in Polyglutamine Disorders: A Synergistic Perspective on Theoretical and Experimental Approaches.Int J Mol Sci. 2024 Jun 20;25(12):6789. doi: 10.3390/ijms25126789. Int J Mol Sci. 2024. PMID: 38928495 Free PMC article. Review.
-
Role of ruscogenin extracted from Radix Ophiopogon Japonicus in antagonizing 5-hydroxytryptamine and dopamine receptors through computational screening.PLoS One. 2024 Nov 19;19(11):e0310960. doi: 10.1371/journal.pone.0310960. eCollection 2024. PLoS One. 2024. PMID: 39561160 Free PMC article.
References
-
- Fuller JC, Burgoyne NJ, Jackson RM. Predicting druggable binding sites at the protein–protein interface. Drug Discov. Today. 2009;14:155–161. - PubMed
-
- Philippe GJB, Craik DJ, Henriques ST. Converting peptides into drugs targeting intracellular protein-protein interactions. Drug Discov. Today. 2021;26:1521–1531. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources